2nd COVID Booster Gives Higher Immunity Than First

A second COVID-19 booster dose against the coronavirus boosts immunity more than the initial or the third dose. The UK rolled out fourth doses to over-75s.

A second COVID-19 booster dose against the coronavirus boosts immunity more than the initial or the third dose, according to a UK trial.

The UK rolled out fourth doses to over-75s and those over the age of 12 who are immunosuppressed in April. It is also offered in Israel and Germany.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘Those who had little waning of their immune responses before their fourth dose gained only a limited increase in their immune responses as a result of the booster — with similar findings for others who had a recent history of a Covid infection.’

"Fourth-dose Covid-19 mRNA booster vaccines are well tolerated and boost cellular and humoral immunity", scientists wrote in the Lancet Infectious Diseases.

Even as short-term protection against infection is likely to fall away quickly, the trial showed that "peak responses after the fourth dose were similar to, and possibly better than, peak responses after the third dose".

Prof. Saul N. Faust, from the University Hospital Southampton and the team explained that third-dose boosters increase humoral and cellular immunity. And they provide more short-term protection against symptomatic infection with variants of concern, including Omicron, compared with a two-dose schedule.

Introducing Plant-Based COVID-19 Vaccine: 70% Effective Against Variants
The COVID-19 vaccine was developed that was made from protein in plants by the researchers at Canadian biotechnology company Medicago and is called "Covifenz."

However, protection against symptomatic infection wanes rapidly following the second and third doses of COVID-19 vaccines.

Fourth-Dose COVID-19 Booster Vaccine

The new trial showed that the fourth dose can rescue immune responses that have waned since a third jab.

"We’ve demonstrated that a fourth dose of Covid-19 vaccines can produce a substantial boost to both the antibody and cellular immunity when you give them more than six months after the third dose," Faust, who led the trial, was quoted as saying to The Guardian.

Bharat Biotech Gets Approval for Covaxin Booster Trials for 2�18 Age Group
Bharat Biotech has sought permission to conduct booster dose trials of Covaxin for population below the age of 18 years, and it has got the permission too.

In the trial, the team analysed data from 133 participants, finding that 14 days after receiving the fourth jab, there was a 1.6-fold increase in antibodies among those who received the Pfizer/BioNTech vaccine.

More than a two-fold increase was observed among those who received the half-dose Moderna jab, compared with 28 days after the third dose, when antibody levels were still at their peak.

FDA to Approve Second Covid Booster Shot
Second Covid-19 vaccine booster may be approved by the Food and Drug Administration (FDA) as early as next week.

The increase in immunity levels was seen for those over and below 70 years of age.

In addition, levels of antibodies and T-cells increased substantially between the day before the fourth vaccination and 14 days after for both types of fourth jab, the report said.

"Our results for immunogenicity are also consistent with the little observational evidence on vaccine effectiveness available from Israel, which indicates increased protection against symptomatic infection and severe illness from a fourth-dose booster," the team wrote in the paper.

"That indicates there may be a ceiling, a maximum antibody level with the T-cell response effects," he said.

Source-IANS